GSP Crop Science IPO open date is March 16, 2026 and the IPO will close on March 18, 2026. GSP Crop Science IPO is a Book build Issue. The company to raise around ₹400 crores via IPO that comprises fresh issue of ₹240 crores and offer for sale up to 50,00,000 equity shares with face value of ₹10 each.(IPO UPDATES)
The company reported revenue of ₹1,301.06 crores in 2025 against ₹1,158.23 crores in 2024. The company reported profit of ₹82.14 crores in 2025 against profit of ₹61.29 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.
GSP Crop Science IPO price band is ₹304 to ₹320 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. GSP Crop Science IPO to list on BSE, NSE on March 24, 2026. The allotment of GSP Crop Science IPO date is March 20, 2026.
GSP Crop Science IPO Date
| Event | Date |
|---|---|
| IPO Open Date | 16 March 2026 |
| IPO Close Date | 18 March 2026 |
| Allotment Date | 20 March 2026 |
| Refund Initiation | 23 March 2026 |
| Shares Credit to Demat | 23 March 2026 |
| Listing Date | 24 March 2026 |
Company Overview
GSP Crop Science Limited is an Ahmedabad-based agrochemical manufacturer engaged in the development and production of crop protection products such as insecticides, herbicides, fungicides, and plant growth regulators. The company sells its products across India and exports to several international markets.
Founded in 1985, the company focuses on research-driven agricultural solutions to improve crop productivity and protect crops from pests and diseases
GSP Crop Science IPO Details (IPO UPDATES)
| Particular | Details |
|---|---|
| IPO Name | GSP Crop Science IPO |
| Face Value | ₹10 per share |
| IPO Type | Book Built Issue |
| Issue Size | Approx. ₹400 Crore |
| Fresh Issue | ₹240 Crore |
| Offer for Sale | 50,00,000 shares |
| Listing Exchange | NSE & BSE |
| Lead Managers | Equirus Capital & Motilal Oswal |
The company aims to raise about ₹400 crore through the IPO
GSP Crop Science IPO Price Band
- Price Band: ₹304 – ₹320 per share
- Lot Size: 46 shares
- Minimum Investment: Around ₹14,720 (approx at upper price band) (IPO UPDATES)
IPO Reservation
| Investor Category | Reservation |
|---|---|
| QIB (Institutional Investors) | 50% |
| Retail Investors | 35% |
| NII / HNI | 15% |
Use of IPO Proceeds
The company plans to use the funds for:
- Debt repayment of existing borrowings
- General corporate purposes
- Strengthening its financial position
Financial Performance
| Year | Revenue | Profit |
|---|---|---|
| FY2024 | ₹1,158 Cr | ₹61.29 Cr |
| FY2025 | ₹1,301 Cr | ₹82.14 Cr |
The company has shown steady revenue growth and improved profitability in recent years.
GSP Crop Science IPO Review
Positive Factors
✔ Growing agrochemical industry in India
✔ Export presence in multiple countries
✔ Strong product portfolio in crop protection chemicals
✔ Improving financial performance
Risk Factors
⚠ High competition from agrochemical companies
⚠ Dependence on agriculture sector demand
⚠ Debt on the balance sheet
Should You Apply for GSP Crop Science IPO?
Experts suggest this IPO may be suitable for long-term investors due to the company’s growing agrochemical business and improving financials. However, investors should also consider valuation and market conditions before investing
Company Office Address
GSP Crop Science Limited
Registered & Corporate Office:
404, Lalita Complex,
Rasala Road, Mithakhali Six Road,
Navrangpura, Ahmedabad – 380009,
Gujarat, India
☎ Phone: +91 79 61915165
📧 Email: cs@gspcrop.com
🌐 Website: www.gspcrop.in
IPO Registrar Office
MUFG Intime India Private Limited
Address:
C-101, 247 Park,
L.B.S. Marg, Vikhroli (West),
Mumbai – 400083, India
☎ Phone: +91-22-4918 6270
📧 Email: gspcrop.ipo@linkintime.co.in
🌐 Website: https://in.mpms.mufg.com
DISCLAMER
The information shared here is intended solely for educational and general awareness purposes. Any securities, investments, or IPO-related details mentioned should not be interpreted as financial advice or investment recommendations. Readers are encouraged to conduct their own independent research or seek guidance from a qualified financial professional before making investment decisions.
IPO-related updates are provided for informational use only. Market trends, past performance, or investor interest do not ensure future outcomes. We are not registered with SEBI. Investments in IPOs and the securities market involve inherent risks, and individuals should carefully evaluate their financial situation or consult a certified financial advisor before investing.
